The national HIV prevalence rate among adults 15-49 years currently stands at 14.3% (2007 ZDHS)…
STUDY DETAILS
- Category Completed Studies
Strengthening TB AIDS and Malaria Prevention Programme (STAMPP)
STAMPP was a five-year project that ran from November 2006 – October 2011. It was funded by the European Union and operated within the Ministry of Health parameters and systems. Its three (3) partner members each brought it’s own strengths.
STAMPP objectives
Overall: To strengthen TB, AIDS and malaria prevention within the framework of comprehensive prevention treatment care strategies directed at the poorest and most vulnerable populations.
Specific: To improve health seeking behaviour of 900,000 beneficiaries in 150,000 households in 6 provinces in Zambia among the risk and vulnerable groups for prevention, care and treatment of TB, HIV and malaria.
Areas of focus
- Developed stakeholder capacity to manage collaborative TB and HIV activities (Household Counseling)
- Developed and strengthened TB/HIV coordinating bodies and committees
- Expanded the household counseling intervention for TB/HIV affected households
- Advocated for policy change in regards to Isoniazid Preventive Therapy (IPT) and Gender
- Promoted behavior change through community health education on TB, HIV and malaria
- Strengthened distribution mechanisms to supply essential health products (condoms, ITNs, chlorine, etc) to communities
- Piloted the integration of TB screening within Mobile VCT
- Established linkages with District Medical Officers, District Health Management Teams
- Development and creation of a TB-specific anti-stigma toolkit
- Conducted a TB and Gender research and disseminated its findings
- Conducted a TB/HIV anti-stigma education programme
- Piloted anti-stigma indicators to measure programmes effectiveness
- Piloted the distribution of IPT for HIV-positive individuals
Expected outputs
Expected Result 1: Increased capacity to deliver integrated TB/HIV and malaria control programmes.
Expected Result 2: Increased access to and demand for essential health products and services.
Expected Result 3: Reduced barriers to health care caused by stigma and discrimination surrounding TB and HIV/AIDS.